Steven Cohen’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Steven Cohen’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-80,000	Closed	-$5.19M	–	2701
2023 Q4	$5.19M	Buy	+80,000	New	+$4.82M	0.01%	904

Other funds holding NARI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Steven Cohen's NARI Position: Q4 2024 in Review

Steven Cohen sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2024, closing a stake of 805,644 shares — an estimated $33.2M sold.

Steven Cohen first reported a position in NARI in Q3 2020 and held it in 13 quarters. The position peaked at $166M in Q1 2023. 258 funds tracked by Wall St. Rank hold NARI as of Q4 2024.

Steven Cohen reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Steven Cohen sold 805,644 Inari Medical, Inc. Common Stock shares in Q4 2024, an estimated $33.2M.
Steven Cohen first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 13 quarters.
Steven Cohen's Inari Medical, Inc. Common Stock position peaked at $166M in Q1 2023.
258 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2024.

Based on Point72 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.